← Back to directory

Andrew J. Lees

Researcher Next ID · RN-029681

Researcher · Medicine

Centre for Movement Disorders

Toronto, United Kingdom

Not currently recruitingFunding unknown
Works count
1,146
Citation count
131,648
H-index
166
i10-index
694

Research interests

Medicine
Neuroscience
Parkinson's Disease Mechanisms and Treatments
Neurological disorders and treatments
Neurological diseases and metabolism
Botulinum Toxin and Related Neurological Disorders
Genetic Neurodegenerative Diseases

Publications

  • Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    The Lancet · 2017 · 10.1016/s0140-6736(17)31585-4

  • Meta‐analysis of early nonmotor features and risk factors for Parkinson disease

    Annals of Neurology · 2012 · https://doi.org/10.1002/ana.23687

  • Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Nature Genetics · 2011 · https://doi.org/10.1038/ng.859

  • Parkinson's disease

    The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)60492-x

  • Second consensus statement on the diagnosis of multiple system atrophy

    Neurology · 2008 · 10.1212/01.wnl.0000324625.00404.15

  • Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

    Nature Medicine · 2008 · https://doi.org/10.1038/nm1746

  • Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

    The Lancet Neurology · 2008 · 10.1016/s1474-4422(08)70117-0

  • Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

    Movement Disorders · 2008 · https://doi.org/10.1002/mds.22340

  • Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

    Movement Disorders · 2007 · 10.1002/mds.21844

  • Clinical diagnostic criteria for dementia associated with Parkinson's disease

    Movement Disorders · 2007 · 10.1002/mds.21507

  • Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan

    Movement Disorders · 2006 · 10.1002/mds.21198

  • A common LRRK2 mutation in idiopathic Parkinson's disease

    The Lancet · 2005 · 10.1016/s0140-6736(05)17830-1

  • Diagnosis and management of dementia with Lewy bodies

    Neurology · 2005 · https://doi.org/10.1212/01.wnl.0000187889.17253.b1

  • Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

    Brain · 2005 · 10.1093/brain/awh445

  • Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease

    Neuron · 2004 · 10.1016/j.neuron.2004.10.023

  • The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

    Brain · 2002 · 10.1093/brain/awf080

  • Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease

    Neurology · 2001 · 10.1212/wnl.57.8.1497

  • Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

    Annals of Neurology · 1994 · 10.1002/ana.410360305

  • What features improve the accuracy of clinical diagnosis in Parkinson's disease

    Neurology · 1992 · 10.1212/wnl.42.6.1142

  • Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

    Journal of Neurology Neurosurgery & Psychiatry · 1992 · https://doi.org/10.1136/jnnp.55.3.181

  • AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY

    Brain · 1991 · https://doi.org/10.1093/brain/114.5.2283

  • ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

    Brain · 1991 · 10.1093/brain/114.4.1953

  • Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

    Annals of Neurology · 1990 · 10.1002/ana.410280412

  • Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

    Journal of Neurochemistry · 1989 · 10.1111/j.1471-4159.1989.tb09133.x

  • The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

    Journal of Neurology Neurosurgery & Psychiatry · 1988 · https://doi.org/10.1136/jnnp.51.6.745

  • INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN

    The Lancet · 1987 · 10.1016/s0140-6736(87)91361-4

  • COGNITIVE DEFICITS IN THE EARLY STAGES OF PARKINSON'S DISEASE

    Brain · 1983 · 10.1093/brain/106.2.257

Current projects

    No projects listed.